Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis
NCT ID: NCT04770857
Last Updated: 2021-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2021-09-01
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Based upon data from studies that have included unselected patients, post-ercp pancreatitis (PEP) is mild, moderate, and severe in 45%, 44%, and 11% of cases, respectively. Dysfunction of the sphincter Oddi, female gender, younger age, previous history of pancreatitis, prolonged procedure time and pancreatic guidewire passages are well-known independent risk factors for PEP.
This study will assess whether the development of PEP can be predicted by Visual analogue scale (VAS) level 1 hour after ERCP.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?
NCT02602574
Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis
NCT06260878
Prediction of PEP Based on the Appearance of the Major Duodenal Papilla
NCT05800626
Late Phase Acute Pancreatitis: a Tailored Step-up Approach
NCT04870268
Effects of High FIO2 on Post-ERCP Pancreatitis.
NCT04876768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Visual analogue scale
Post procedural pain assessment using the visual analogue scale (VAS) will be performed in patients undergoing ERCP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for ERCP for any reason
Exclusion Criteria
* Language barrier
* No endoscopic advance to the papilla vateri
* Active pancreatitis at the time of the procedure
* Mental disability
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nicola Frei
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicola Frei
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Sankt Gallen
Sankt Gallen, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTU 19/036
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.